Sorry, you need to enable JavaScript to visit this website.

This website is intended for healthcare professionals in KSA and UAE only.

The content provided is developed in accordance with local regulations and may not be applicable or compliant in other regions.

This website is intended for healthcare professionals in KSA and UAE only.
 The content provided is developed in accordance with local regulations and may not be applicable or compliant in other regions.

Reporting adverse events
Reporting adverse events
CSL_Logo
Log in
Icon Search
hamburguer menu

Search results

hamburguer menu
Log in
Submitted by Site Factory admin on

Discover the long-term data - Veltassa® was associated with a lower risk of all-cause mortality among patients with CKD and hyperkalemia.2

Veltassa Resource Image
Outcomes: The Veteran Study
Resource Type
PDF
Main Title

Outcomes: The Veteran Study 

Report adverse events in the UK


Adverse events should be reported. Reporting forms and
information for United Kingdom can be found at https://
yellowcard.mhra.gov.uk/ or search for MHRA Yellow Card in the
Google Play or Apple App Store. Adverse events should also be
reported to Vifor Pharma Ltd. Tel: +44 1276 853633. E-
mail: medicalInfo_UK@viforpharma.com

Help us guide you to the right place

audience-Icon

I am a KSA & UAE health
care professional or KSA & UAE
healthcare decision
maker

This is me, continue
icon-arrow-right
audience-Icon

I am not a KSA & UAE health
care professional or KSA & UAE
healthcare decision
maker

This is me, continue
icon-arrow-right